The introduction of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Ozempic and Wegovy) is a breakthrough in the management of obesity. These medications have proven to be very effective in promoting weight loss and improving blood sugar levels. While a lot of people may think that I have something against GLP-1s – whether because…

The post Why GLP-1 Medications May Not Solve the Obesity Epidemic appeared first on Abby Langer Nutrition.